INDOUS
Start SIP
Invest Now
Start SIP in INDOUS
Performance
- Low
- ₹126
- High
- ₹134
- 52 Week Low
- ₹105
- 52 Week High
- ₹235
- Open Price₹129
- Previous Close₹130
- Volume16,407
- 50 DMA₹124.86
- 100 DMA₹130.44
- 200 DMA₹146.59
Investment Returns
- Over 1 Month + 11.95%
- Over 3 Month -3.73%
- Over 6 Month -22.89%
- Over 1 Year -41.85%
Smart Investing Starts Here Start SIP with Indo US Bio-Tech for Steady Growth!
Indo US Bio-Tech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 17.1
- PEG Ratio
- 1.3
- Market Cap Cr
- 254
- P/B Ratio
- 2.9
- Average True Range
- 9.74
- EPS
- 7.4
- Dividend Yield
- 0
- MACD Signal
- 1.79
- RSI
- 53.13
- MFI
- 80.25
Indo US Bio-Tech Financials
Indo US Bio-Tech Technicals
EMA & SMA
Current Price
₹126.50
-5.4
(-4.09%)
- Bearish Moving Average 0
- Bullish Moving Average 0
- 20 Day
- ₹125.57
- 50 Day
- ₹124.86
- 100 Day
- ₹130.44
- 200 Day
- ₹146.59
Resistance and Support
132.3
- R3 159.15
- R2 151.85
- R1 139.60
- S1 120.05
- S2 112.75
- S3 100.50
Indo US Bio-Tech Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-01-21 | Quarterly Results | |
| 2025-11-14 | Quarterly Results | |
| 2025-10-14 | Others | Inter-alia, to consider 1. Re-appointment of M/s. Gautam N Associates as a Statutory Auditors of the Company. 2. Approve Notice of Postal Ballot. 3. Other business matters. per share(2.5%)Interim Dividend |
| 2025-08-12 | Quarterly Results | |
| 2025-05-26 | Audited Results |
Indo US Bio-Tech F&O
About Indo US Bio-Tech
- NSE Symbol
- INDOUS
- BSE Symbol
- 541304
- Managing Director
- Mr. Jagdish Ajudia
- ISIN
- INE250Z01010
Similar Stocks to Indo US Bio-Tech
Indo US Bio-Tech FAQs
Indo US Bio-Tech share price is ₹126 As on 13 February, 2026 | 03:12
The Market Cap of Indo US Bio-Tech is ₹253.7 Cr As on 13 February, 2026 | 03:12
The P/E ratio of Indo US Bio-Tech is 17.1 As on 13 February, 2026 | 03:12
The PB ratio of Indo US Bio-Tech is 2.9 As on 13 February, 2026 | 03:12
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.